Review of operations For the Half Year Ended 31 December 2024 The Group continued to engage in its principal activities being the development, sales and support of healthcare applications for healthcare providers operating in a variety of delivery settings. The results are disclosed in the attached...
Global Health achieves turnaround results in 2024 Global Health Limited (ASX:GLH) (“Global Health” or “the Group”) is pleased to release its 2024 Annual Report, announcing a transformational 12 months to June 2024 completing a turnaround which positions the group to transition back into sustainable profitability and...
Result highlights include: Revenue up 27% or $856K to $4.039M Expenses reduced by 12% or $0.69M to ($5.2M) EBITDA up 58% or $1.5M to ($1M) Innovation investments (R&D) increase 84% to $1.468M Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release...
Global Health is excited to present our Annual Report, showcasing our achievements in the past year. The highlights include: 20% increase in Customer Revenue to $7.81 million 11% growth in Annual Recurring Revenue reaching $5.73 million 47% rise in Gross Margin, totaling $4.12 million. In addition, we...
Read the Global Health Limited Half Year Update here: FY21 Half Year Business Update To read more on the ASX click here: ASX Market Announcements - GLH...
Read the Half Yearly Report and Accounts here: 2020-02 Half Yearly Report and Accounts...
Read the Half Year Results Announcement: 2020-02 Half Year Results Announcement...
Read the June 2019 Annual Report to Shareholders here: June 2019 Annual Report to Shareholders...
Please view the Annual Report via this link: June 2019 Preliminary Financial Report here...
Please view the Preliminary Financial Report CEO Commentary via this link: Global Health Preliminary Financial Report CEO Commentary here...